The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics

The infectious severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative agent for coronavirus disease 2019 (COVID-19). Globally, there have been millions of infections and fatalities. Unfortunately, the virus has been persistent and a contributing factor is the emergence of seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Naidoo, Dhaneshree Bestinee, Chuturgoon, Anil Amichund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850341/
https://www.ncbi.nlm.nih.gov/pubmed/36656511
http://dx.doi.org/10.1007/s40291-022-00634-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850341/
https://www.ncbi.nlm.nih.gov/pubmed/36656511
http://dx.doi.org/10.1007/s40291-022-00634-x

Ejemplares similares